Lim SM - Search Results

1

Inhibition of HIF-1α by Atorvastatin During ¹³¹I-RTX Therapy in Burkitt's Lymphoma Model.

Kim EH, Ko HY, Yu AR, Kim H, Zaheer J, Kang HJ, Lim YC, Cho KD, Joo HY, Kang MK, Lee JJ, Lee SS, Kang HJ, Lim SM, Kim JS. Kim EH, et al. Among authors: lim yc, lim sm. Cancers (Basel). 2020 May 11;12(5):1203. doi: 10.3390/cancers12051203. Cancers (Basel). 2020. PMID: 32403237 Free PMC article.

2

Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.

Chung JH, Cho KJ, Lee SS, Baek HJ, Park JH, Cheon GJ, Choi CW, Lim SM. Chung JH, et al. Among authors: lim sm. J Nucl Med. 2004 Jun;45(6):999-1003. J Nucl Med. 2004. PMID: 15181136 Free article. Clinical Trial.

3

18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer.

Na II, Byun BH, Kang HJ, Cheon GJ, Koh JS, Kim CH, Choe DH, Ryoo BY, Lee JC, Lim SM, Yang SH. Na II, et al. Among authors: lim sm. Clin Cancer Res. 2008 Apr 1;14(7):2036-41. doi: 10.1158/1078-0432.CCR-07-4074. Clin Cancer Res. 2008. PMID: 18381942

4

Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.

Byun BH, Na II, Cheon GJ, Kang HJ, Kim KM, Lee SS, Ryoo BY, Choi CW, Lim SM, Yang SH. Byun BH, et al. Among authors: lim sm. Ann Nucl Med. 2008 Oct;22(8):645-51. doi: 10.1007/s12149-008-0181-9. Epub 2008 Nov 4. Ann Nucl Med. 2008. PMID: 18982466

5

Radioimmunotherapy with (131)I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL).

Kang HJ, Lee SS, Kim KM, Choi TH, Cheon GJ, Kim WS, Suh C, Yang SH, Lim SM. Kang HJ, et al. Among authors: lim sm. Asia Pac J Clin Oncol. 2011 Jun;7(2):136-45. doi: 10.1111/j.1743-7563.2011.01393.x. Asia Pac J Clin Oncol. 2011. PMID: 21585693 Clinical Trial.

6

Validation of a postinjection transmission method for actual rat brain PET.

Kim JS, Yu AR, Kim KM, Oh SJ, Ryu JS, Kim HJ, Lim SM. Kim JS, et al. Among authors: lim sm. Med Phys. 2012 Sep;39(9):5614-20. doi: 10.1118/1.4747263. Med Phys. 2012. PMID: 22957627

7

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Kang HJ, Lee SS, Byun BH, Kim KM, Lim I, Choi CW, Suh C, Kim WS, Nam SH, Lee SI, Eom HS, Shin DY, Lim SM. Kang HJ, et al. Among authors: lim i, lim sm. Cancer Chemother Pharmacol. 2013 Apr;71(4):945-53. doi: 10.1007/s00280-013-2087-z. Epub 2013 Jan 31. Cancer Chemother Pharmacol. 2013. PMID: 23370662 Clinical Trial.

8

Prognostic significance of pretreatment ¹⁸F-FDG PET/CT in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma treated by radioimmunotherapy using ¹³¹I-rituximab.

Lim I, Park JY, Kang HJ, Hwang JP, Lee SS, Kim KM, Choi TH, Yang SH, Kim BI, Choi CW, Lim SM. Lim I, et al. Among authors: lim sm. Acta Haematol. 2013;130(2):74-82. doi: 10.1159/000346436. Epub 2013 Mar 20. Acta Haematol. 2013. PMID: 23548464

9

Performance measurement of PSF modeling reconstruction (True X) on Siemens Biograph TruePoint TrueV PET/CT.

Lee YS, Kim JS, Kim KM, Kang JH, Lim SM, Kim HJ. Lee YS, et al. Among authors: lim sm. Ann Nucl Med. 2014 May;28(4):340-8. doi: 10.1007/s12149-014-0815-z. Epub 2014 Feb 7. Ann Nucl Med. 2014. PMID: 24504938

10

Radioimmunotherapy with (131)i-rituximab in a patient with diffuse large B-cell lymphoma relapsed after treatment with (90)y-ibritumomab tiuxetan.

Kang GW, Kang HJ, Shin DY, Gu HR, Choi HS, Lim SM. Kang GW, et al. Among authors: lim sm. Nucl Med Mol Imaging. 2013 Dec;47(4):281-4. doi: 10.1007/s13139-013-0229-1. Epub 2013 Aug 30. Nucl Med Mol Imaging. 2013. PMID: 24900126 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

921 results

Search Page